> top > docs > PubMed:24616092 > spans > 658-921 > annotations

PubMed:24616092 / 658-921 JSONTXT

Annnotations TAB JSON ListView MergeView

GlyCosmos6-Glycan-Motif-Image

Id Subject Object Predicate Lexical cue image
T7 102-110 Glycan_Motif denotes O-GlcNAc https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G89565QL|https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G49108TO
T9 191-199 Glycan_Motif denotes O-GlcNAc https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G89565QL|https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G49108TO

sentences

Id Subject Object Predicate Lexical cue
T6 0-263 Sentence denotes O-(2-acetamido-2-deoxy-D-glucopyranosylidene) amino N-phenylcarbamate (PUGNAc), a drug that increases O-GlcNAc, augmented the expression of ChREBP targets, whereas DON, a drug that decreases O-GlcNAc and O-GlcNAcase overexpression, mitigated the increase with HG.

GlyCosmos6-Glycan-Motif-Structure

Id Subject Object Predicate Lexical cue
T7 102-110 https://glytoucan.org/Structures/Glycans/G49108TO denotes O-GlcNAc
T8 102-110 https://glytoucan.org/Structures/Glycans/G89565QL denotes O-GlcNAc
T9 191-199 https://glytoucan.org/Structures/Glycans/G49108TO denotes O-GlcNAc
T10 191-199 https://glytoucan.org/Structures/Glycans/G89565QL denotes O-GlcNAc

Glycosmos6-GlycoEpitope

Id Subject Object Predicate Lexical cue glyco_epitope_db_id
T2 102-110 GlycoEpitope denotes O-GlcNAc http://www.glycoepitope.jp/epitopes/EP0004
T3 191-199 GlycoEpitope denotes O-GlcNAc http://www.glycoepitope.jp/epitopes/EP0004

NGLY1-deficiency

Id Subject Object Predicate Lexical cue
PD-NGLY1-deficiency-B_T2 104-110 chem:24139 denotes GlcNAc
PD-NGLY1-deficiency-B_T3 193-199 chem:24139 denotes GlcNAc

mondo_disease

Id Subject Object Predicate Lexical cue mondo_id
T4 164-167 Disease denotes DON http://purl.obolibrary.org/obo/MONDO_0000840

Glycan-GlyCosmos

Id Subject Object Predicate Lexical cue image
T2 102-110 Glycan denotes O-GlcNAc https://api.glycosmos.org/wurcs2image/latest/png/binary/G49108TO
T3 191-199 Glycan denotes O-GlcNAc https://api.glycosmos.org/wurcs2image/latest/png/binary/G49108TO

GlyCosmos-GlycoEpitope

Id Subject Object Predicate Lexical cue glycoepitope_id
T2 102-110 http://purl.jp/bio/12/glyco/glycan#Glycan_epitope denotes O-GlcNAc http://www.glycoepitope.jp/epitopes/EP0004
T3 191-199 http://purl.jp/bio/12/glyco/glycan#Glycan_epitope denotes O-GlcNAc http://www.glycoepitope.jp/epitopes/EP0004

GlyCosmos15-MONDO

Id Subject Object Predicate Lexical cue mondo_id
T4 164-167 Disease denotes DON http://purl.obolibrary.org/obo/MONDO_0000840

sentences

Id Subject Object Predicate Lexical cue
T6 0-263 Sentence denotes O-(2-acetamido-2-deoxy-D-glucopyranosylidene) amino N-phenylcarbamate (PUGNAc), a drug that increases O-GlcNAc, augmented the expression of ChREBP targets, whereas DON, a drug that decreases O-GlcNAc and O-GlcNAcase overexpression, mitigated the increase with HG.

GlyCosmos15-Sentences

Id Subject Object Predicate Lexical cue
T6 0-263 Sentence denotes O-(2-acetamido-2-deoxy-D-glucopyranosylidene) amino N-phenylcarbamate (PUGNAc), a drug that increases O-GlcNAc, augmented the expression of ChREBP targets, whereas DON, a drug that decreases O-GlcNAc and O-GlcNAcase overexpression, mitigated the increase with HG.

GlyCosmos15-Glycan

Id Subject Object Predicate Lexical cue image
T2 102-110 Glycan denotes O-GlcNAc https://api.glycosmos.org/wurcs2image/latest/png/binary/G49108TO
T3 191-199 Glycan denotes O-GlcNAc https://api.glycosmos.org/wurcs2image/latest/png/binary/G49108TO

GlyCosmos15-GlycoEpitope

Id Subject Object Predicate Lexical cue glycoepitope_id
T2 102-110 http://purl.jp/bio/12/glyco/glycan#Glycan_epitope denotes O-GlcNAc http://www.glycoepitope.jp/epitopes/EP0004
T3 191-199 http://purl.jp/bio/12/glyco/glycan#Glycan_epitope denotes O-GlcNAc http://www.glycoepitope.jp/epitopes/EP0004